Hamlin PJ - Search Results

1

Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease.

Choi GK, Collins SD, Greer DP, Warren L, Dowson G, Clark T, Hamlin PJ, Ford AC. Choi GK, et al. Among authors: hamlin pj. J Crohns Colitis. 2014 May;8(5):375-83. doi: 10.1016/j.crohns.2013.09.017. Epub 2013 Oct 12. J Crohns Colitis. 2014. PMID: 24129316

2

Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience.

Sprakes MB, Ford AC, Suares NC, Warren L, Greer D, Donnellan CF, Jennings JS, Everett SM, Hamlin PJ. Sprakes MB, et al. Among authors: hamlin pj. Aliment Pharmacol Ther. 2010 Dec;32(11-12):1357-63. doi: 10.1111/j.1365-2036.2010.04482.x. Epub 2010 Oct 7. Aliment Pharmacol Ther. 2010. PMID: 21050238

3

Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.

Suares NC, Hamlin PJ, Greer DP, Warren L, Clark T, Ford AC. Suares NC, et al. Among authors: hamlin pj. Aliment Pharmacol Ther. 2012 Jan;35(2):284-91. doi: 10.1111/j.1365-2036.2011.04925.x. Epub 2011 Nov 24. Aliment Pharmacol Ther. 2012. PMID: 22112005

4

Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission.

Brooks AJ, Sebastian S, Cross SS, Robinson K, Warren L, Wright A, Marsh AM, Tsai H, Majeed F, McAlindon ME, Preston C, Hamlin PJ, Lobo AJ. Brooks AJ, et al. Among authors: hamlin pj. J Crohns Colitis. 2017 Dec 4;11(12):1456-1462. doi: 10.1016/j.crohns.2014.09.007. J Crohns Colitis. 2017. PMID: 25311864

5

Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.

Sprakes MB, Hamlin PJ, Warren L, Greer D, Ford AC. Sprakes MB, et al. Among authors: hamlin pj. J Crohns Colitis. 2011 Aug;5(4):324-31. doi: 10.1016/j.crohns.2011.02.007. Epub 2011 Mar 10. J Crohns Colitis. 2011. PMID: 21683302 Clinical Trial.

6

Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.

Halpin SJ, Hamlin PJ, Greer DP, Warren L, Ford AC. Halpin SJ, et al. Among authors: hamlin pj. World J Gastroenterol. 2013 Feb 21;19(7):1091-7. doi: 10.3748/wjg.v19.i7.1091. World J Gastroenterol. 2013. PMID: 23467174 Free PMC article.

7

Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.

Burr NE, Hall B, Hamlin PJ, Selinger CP, Ford AC, O'Connor A. Burr NE, et al. Among authors: hamlin pj. J Crohns Colitis. 2019 May 27;13(6):693-701. doi: 10.1093/ecco-jcc/jjy216. J Crohns Colitis. 2019. PMID: 30561586 Free article.

8

Long-term efficacy and safety of azathioprine in ulcerative colitis.

Sood R, Ansari S, Clark T, Hamlin PJ, Ford AC. Sood R, et al. Among authors: hamlin pj. J Crohns Colitis. 2015 Feb;9(2):191-7. doi: 10.1093/ecco-jcc/jju010. J Crohns Colitis. 2015. PMID: 25518053 Clinical Trial.

9

Postoperative prophylaxis in Crohn's disease after intestinal resection: a retrospective analysis.

O'Connor A, Hamlin PJ, Taylor J, Selinger C, Scott N, Ford AC. O'Connor A, et al. Among authors: hamlin pj. Frontline Gastroenterol. 2017 Jul;8(3):203-209. doi: 10.1136/flgastro-2016-100749. Epub 2016 Dec 1. Frontline Gastroenterol. 2017. PMID: 28839910 Free PMC article.

10

Mycophenolate mofetil therapy for refractory inflammatory bowel disease.

Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ. Palaniappan S, et al. Among authors: hamlin pj. Inflamm Bowel Dis. 2007 Dec;13(12):1488-92. doi: 10.1002/ibd.20258. Inflamm Bowel Dis. 2007. PMID: 17924566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters